NKTX Stock — Nkarta, Inc.: Metrics

Market overview

2 metrics

Share price

$2.77

Market cap

$193.39M

Price action

19 metrics

Price change (1W)

-0.4%

Price change (30D)

+25.6%

Price change (3M)

-7.2%

Price change (6M)

+5.1%

Price change (YTD)

+45.9%

Price change (1Y)

+27.4%

Trailing year

Price change (5Y)

-91.7%

52-week high

$3.67

52-week low

$1.73

Change from 52-week high

-26.4%

Change from 52-week low

+56.1%

Annualized volatility

74.0%

Beta

2.1

RSI (14D)

57.0

Price vs SMA 50

+3.4%

Price vs SMA 200

+11.5%

Avg volume (3M)

653,964

Relative volume

0.9

Average dollar volume

$1.75M

Company

3 metrics

Sector

Healthcare

Industry

Biotechnology

Shares outstanding

71.62M

Valuation

12 metrics

P / E (TTM)

—

Trailing earnings

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

—

P / book

0.8

reciprocal yield 128.1%

FCF yield

—

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

-60.7%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

2025-11-13

Profitability

9 metrics

Gross margin

—

Operating margin

—

Trailing 12 months

Net margin

—

Gross profit (TTM)

—

Operating profit (TTM)

−$132.25M

Net income (TTM)

−$117.32M

Trailing 12 months

Diluted EPS (TTM)

$-1.58

FCF margin

—

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$-15.92

Growth

11 metrics

Revenue growth YoY

—

Year over year

Net income growth YoY

—

Revenue (TTM)

—

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+0.7%

Year over year · more shares

Revenue CAGR (3Y)

—

Revenue CAGR (5Y)

—

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

-47.4%

Return on assets

-34.7%

Debt / equity

—

Current ratio

8.0

EBITDA (TTM)

−$122.65M

Free cash flow (TTM)

—

Quick ratio

8.0

Interest coverage

—

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

$182.76M

Latest balance sheet

Cash & equivalents

$24.96M

Total assets

$337.64M

Total debt

—

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$92.76M

Capital expenditures (TTM)

—

R&D (TTM)

$99.51M

SG&A (TTM)

—

Stock compensation (TTM)

$7.43M

R&D / revenue

—

Stock compensation / revenue

—

Ownership (13F)

3 metrics

13F filers

136

13F filer change QoQ

+10

Institutional ownership

83.0%

Short interest

3 metrics

Short interest

5.0%

Latest settlement · 6.3 days to cover

Days to cover

6.3d

Short-squeeze score

67 / 100

Insider activity

2 metrics

Net insider buying (90D)

−$4,813

Insider-sentiment score

57 / 100

Risk flags

1 metrics

Going concern

—

NKTX · Nkarta, Inc.

NKTX metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search